prikaz prve stranice dokumenta Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis
  Preuzmi
PDF 604.38 KB
Znanstveni rad - Pregledni rad
Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis
Therapeutic Advances in Gastroenterology, 16 (2023); 17562848231174290. https://doi.org/10.1177/17562848231174290
Prokopič, Michal; Gilca-Blanariux, Georgiana; Lietava, Peter; Trifan, Anca; Pietrzak, Anna; Ladić, Agata; Brinar, Marko; Turcan, Svetlana; Molnár, Tamás; Bánovčin, Peter; Lukáš, Milan

Citirajte ovaj rad

Prokopič, M., Gilca Blanariux, G., Lietava, P., Trifan, A., Pietrzak, A., Ladić, A. ... Lukáš, M. (2023). Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis. Therapeutic Advances in Gastroenterology, 16.. doi: 10.1177/17562848231174290

Prokopič, Michal, et al. "Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis." Therapeutic Advances in Gastroenterology, vol. 16, 2023. https://doi.org/10.1177/17562848231174290

Prokopič, Michal, Georgiana Gilca Blanariux, Peter Lietava, Anca Trifan, Anna Pietrzak, Agata Ladić, Marko Brinar, et al. "Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis." Therapeutic Advances in Gastroenterology 16 (2023). https://doi.org/10.1177/17562848231174290

Prokopič, M., et al. (2023) 'Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis', Therapeutic Advances in Gastroenterology, 16. doi: 10.1177/17562848231174290

Prokopič M, Gilca Blanariux G, Lietava P, Trifan A, Pietrzak A, Ladić A, i sur.. Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis. Therapeutic Advances in Gastroenterology [Internet]. 12.06.2023. [pristupljeno 16.04.2024.];16. doi: 10.1177/17562848231174290

M. Prokopič, et al., "Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis", Therapeutic Advances in Gastroenterology, vol. 16, Lipanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:978759. [Citirano: 16.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:978759
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis
AutorMichal Prokopič
AutorGeorgiana Gilca-Blanariux
AutorPeter Lietava
AutorAnca Trifan
AutorAnna Pietrzak
AutorAgata Ladić
AutorMarko Brinar
AutorSvetlana Turcan
AutorTamás Molnár
AutorPeter Bánovčin
AutorMilan Lukáš
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic immune-mediated diseases with a high incidence and prevalence in Europe. Since these are diseases with associated disability, they require complex management and the availability of high-quality healthcare resources. We focused on the analysis of IBD care in selected countries of Central and Eastern Europe (Croatia, the Czech Republic, Hungary, Moldova, Poland, Romania and Slovakia) targeting the availability and reimbursement of diagnostic and therapeutic modalities, the role of IBD centers and also education and research in IBD. As part of the analysis, we created a questionnaire of 73 statements organized in three topics: (1) diagnostics, follow-up and screening, (2) medications and (3) IBD centers. The questionnaire was filled out by co-authoring IBD experts from individual countries, and then the answers and comments on the questionnaire were analyzed. We identified that despite the financial burden, which still partially persists in the region, the availability of some of the cost-saving tools (calprotectin test, therapeutic drug monitoring) differs among countries, mainly due to variable reimbursement from country to country. In most participating countries, there also remains a lack of dedicated dietary and psychological counseling, which is often replaced by recommendations offered by gastroenterologists. However, there is adequate availability of most of the currently recommended diagnostic methods and therapies in each participating country, as well as the implementation of established IBD centers in the region.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaTherapeutic Advances in Gastroenterology
Brojčani podacivol. 16, 17562848231174290
p-ISSN1756-2848
e-ISSN1756-2848
DOIhttps://doi.org/10.1177/17562848231174290
URN:NBNurn:nbn:hr:105:978759
Datum objave publikacije2023-06-12
URL dokumentahttp://journals.sagepub.com/doi/10.1177/17562848231174290
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2023-09-28 08:07:54